Anirban Maitra: This was Cullen’s baby from the very preclinical inception in his lab
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at the University of Texas MD Anderson Cancer Center, shared a post on X/Twitter:
“Congratulations Cullen Taniguchi– I know how incredibly proud you are of this The Lancet Oncology study out today. Your paper made the cover highlight! This was Cullen’s baby from the very preclinical inception in his lab, and it breaks my heart that I can’t shake his hand in person. Stereotactic body radiotherapy with or without selective dismutase mimetic in Pancreatic Cancer: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial.
In honor of Cullen and his work, from MD Anderson Cancer Center (in collaboration with Moffitt Cancer Center) Read more here.”
For details click here.
Source: Anirban Maitra/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023